Therapeutic targeting of the KIF18A motor protein in cancers with chromosomal instability

被引:0
|
作者
Payton, Marc [1 ]
Hughes, Paul E. [1 ]
机构
[1] Amgen Res, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1038/s43018-023-00700-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosomal instability (CIN) (a hallmark of human cancer) is caused by persistent errors in chromosome segregation during mitosis. Pharmacological inhibition of the mitotic kinesin KIF18A selectively exploits a mitotic vulnerability for which cancer models with CIN are enriched, which leads to robust anti-cancer effects and durable tumor regression in mice.
引用
收藏
页码:10 / 11
页数:2
相关论文
共 38 条
  • [2] Targeting the mitotic kinesin, KIF18A, in chromosomally unstable cancers
    Joseph, James D.
    Schutt, Katherine
    Fisher, Kira
    Queen, Katelyn
    Budington, Olivia
    Mao, Weifeng
    Liu, Wei
    Zhu, Zhengqing
    Zhang, Xiangping
    Xiao, Yisong
    Lai, Kunmin
    Gu, Xiaohui
    Stumpff, Jason
    Aswad, Fred
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype
    Liu, Gang
    Zhang, Yan
    Cao, Zhen
    Zhao, Zhanwei
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [4] BTB-1: A Small Molecule Inhibitor of the Mitotic Motor Protein Kif18A
    Catarinella, Mario
    Gruener, Tamara
    Strittmatter, Tobias
    Marx, Andreas
    Mayer, Thomas U.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (48) : 9072 - 9076
  • [5] Targeting chromosomally unstable tumors with a selective KIF18A inhibitor
    Phillips, Aaron F.
    Zhang, Rumin
    Jaffe, Mia
    Schulz, Ryan
    Carty, Marysol Chu
    Verma, Akanksha
    Feinberg, Tamar Y.
    Arensman, Michael D.
    Chiu, Alan
    Letso, Reka
    Bosco, Nazario
    Queen, Katelyn A.
    Racela, Allison R.
    Stumpff, Jason
    Andreu-Agullo, Celia
    Bettigole, Sarah E.
    Depetris, Rafael S.
    Drutman, Scott
    Su, Shinsan M.
    Cogan, Derek A.
    Eng, Christina H.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [6] Targeting chromosomally unstable tumors with a selective KIF18A inhibitor
    Phillips, Aaron F.
    Zhang, Rumin
    Verma, Akanksha
    Feinberg, Tamar
    Jaffe, Mia
    Carty, Marysol Chu
    Schulz, Ryan
    Bettigole, Sarah
    Andreu, Celia
    Drutman, Scott
    Su, Michael
    Cogan, Derek
    Eng, Christina H.
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe
    Tamayo, Nuria A.
    Bourbeau, Matthew P.
    Allen, Jennifer R.
    Ashton, Kate S.
    Chen, Jian Jeffrey
    Kaller, Matthew R.
    Nguyen, Thomas T.
    Nishimura, Nobuko
    Pettus, Liping H.
    Walton, Mary
    Belmontes, Brian
    Moriguchi, Jodi
    Chen, Kui
    McCarter, John D.
    Hanestad, Kelly
    Chung, Grace
    Ninniri, Maria Stefania S.
    Sun, Jan
    Poppe, Leszek
    Spahr, Chris
    Hui, John
    Jia, Lei
    Wu, Tian
    Dahal, Upendra P.
    Edson, Katheryne Z.
    Payton, Marc
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (06) : 4972 - 4990
  • [8] Exploration of inhibitors targeting KIF18A with ploidy-specific lethality
    Chen, Qingsong
    Le, Xiangyang
    Li, Qianbin
    Liu, Suyou
    Chen, Zhuo
    DRUG DISCOVERY TODAY, 2024, 29 (10)
  • [9] Discovery and preclinical characterization of novel small molecule inhibitors of kinesin KIF18A motor protein with potent activity against chromosomally unstable cancers.
    Sun, Jan
    Belmontes, Brain
    Moriguchi, Jodi
    Chung, Grace
    Chen, Kui
    McCarter, John D.
    Dahal, Upendra P.
    Boghossian, Andrew S.
    Rees, Matthew G.
    Ronan, Melissa M.
    Roth, Jennifer A.
    Minocherhomji, Sheroy
    Bourbeau, Matthew P.
    Allen, Jennifer R.
    Coxon, Angela
    Hughes, Paul E.
    Tamayo, Nuria
    Payton, Marc N.
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Relevance of aneuploidy for cancer therapies targeting the spindle assembly checkpoint and KIF18A
    Cohen-Sharir, Yael
    Ben-David, Uri
    MOLECULAR & CELLULAR ONCOLOGY, 2021, 8 (03)